Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient, and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics, and computer science. Sight’s first product, Parasight, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US, and Israel, and a commercial footprint on 5 continents. Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.